Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Brain Neoplasms × Drug Therapy × Clear all

Phase

Phase 2 4 Phase 1 4 Phase NA 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 21 Breast Neoplasms 15 Colorectal Neoplasms 13 Ovarian Neoplasms 10 Lung Neoplasms 10 Neoplasm Metastasis 9 Stomach Neoplasms 8 Nasopharyngeal Carcinoma 7 Leukemia, Myeloid, Acute 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasms 6 Recurrence 5 Rectal Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Fallopian Tube Neoplasms 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Leukemia 4 Head and Neck Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Pancreatic Neoplasms 3 Lymphoma, Non-Hodgkin 3 Esophageal Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Neoplasms by Site 2 Multiple Myeloma 2 Melanoma 2

Interventions

Radiosurgery 21 Radiotherapy 19 Temozolomide 15 Lomustine 8 Bevacizumab 7 Surgical Procedures, Operative 6 Procarbazine 6 Vincristine 5 Nivolumab 5 Memantine 4 Filgrastim 4 Etoposide 4 Cisplatin 4 Carboplatin 4 Sodium Chloride 3 Radiation 3 Magnetic Resonance Spectroscopy 3 Granulocyte Colony-Stimulating Factor 3 Cyclophosphamide 3 Corticotropin-Releasing Hormone 3 icotinib 2 etoposide phosphate 2 efaproxiral 2 X-Rays 2 Tranexamic Acid 2 Tf-CRM107 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Conformal 2 Platinum 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03632135 2025-04-15

CSCRGBM

Cordgenics, LLC

Phase 3 Completed

78 enrolled 10 charts

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡